ストックスクリーナーアプリを入手
74.16
2.96%
-2.26
アフターアワーズ：
73.70
-0.46
-0.62%
Illumina Inc (ILMN) 最新ニュース
Epigenetics Market Deep Research 2025-2032 | Illumina Inc., Thermo Fisher Scientific Inc., Merck Millipore Limited - openPR.com
Illumina stock hits 52-week low at $70.88 amid market challenges - Investing.com
Here's Why Illumina (ILMN) is a Strong Value Stock - Yahoo
Global Agrigenomics Market Is Booming So Rapidly 2025-2032 | BGI, Illumina, Inc., Eurofins Scientific SE - openPR.com
How Illumina employees step up, reach out, and give back - Illumina
Trexquant Investment LP Buys 20,506 Shares of Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Characterizing alveolar dysregulation in pulmonary fibrosis using Illumina Spatial Technology - Illumina
Personalized Medicine Market Growth Trends 2025-2033: Transition to Customized Medical Care, Developments in Bioinformatics and Genomics, Growing Prevalence of Chronic Diseases - GlobeNewswire Inc.
Here's How Much $1000 Invested In Illumina 20 Years Ago Would Be Worth TodayIllumina (NASDAQ:ILMN) - Benzinga
Argus cuts Illumina target, sees buying opportunity - Yahoo Finance
Illumina careers: Expanding access to NGS in emerging markets - Illumina
The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics - Nasdaq
Corvex’s Meister joins the board at Illumina. Here’s how he can create value for shareholders - MSN
Illumina, Inc. (NASDAQ:ILMN) Shares Sold by Artisan Partners Limited Partnership - MarketBeat
Corvex's Meister joins the board at Illumina. Here's how he can create value for shareholders - NBC Connecticut
Illumina Adds Activist to Board, Names Former FDA Chief as Chair - MSN
Illumina stock hits 52-week low at $80.18 amid market challenges By Investing.com - Investing.com South Africa
Illumina stock hits 52-week low at $80.18 amid market challenges - Investing.com India
New in the lab: Test driving the MiSeq i100 Plus - Illumina
Analyst recommendations: Illumina, Boeing, Next, Walmart, Applovin.... - MarketScreener
AI In Genomics Market to Reach $9.8 Billion, Globally, by 2031 - openPR
NGS Sample Preparation Market Techniques Reshaping Genomic - openPR
Cathie Wood’s ARK trims Illumina, exits Repare Therapeutics stock By Investing.com - Investing.com South Africa
Cathie Wood’s ARK trims Illumina, exits Repare Therapeutics stock - Investing.com
May 9th Options Now Available For Illumina (ILMN) - Nasdaq
Is Illumina Undervalued After An 83% Drop In Its Stock Price? (NASDAQ:ILMN) - Seeking Alpha
Illumina is Now Oversold (ILMN) - Nasdaq
Canaccord maintains Illumina stock hold with $115 target By Investing.com - Investing.com UK
Activist investor Keith Meister to join Illumina's board - Reuters
Activist Investors Seize More Control of Illumina Amid Weakness - Markets Insider
Canaccord holds Illumina stock with $115 target amid board changes By Investing.com - Investing.com UK
Cintas, UPS, Illumina: Market Minute - Yahoo Finance
Illumina rises after board revamp - MSN
Illumina stock rises after board revamp (ILMN:NASDAQ) - Seeking Alpha
Activist Investor Meister to Join Illumina’s Board - WSJ
Activist investor Keith Meister to join Illumina’s board, WSJ reports - 1470 & 100.3 WMBD
Illumina Names Scott Gottlied as Non-Executive Board Chair; Corvex's Keith Meister Joins Board - MarketScreener
Illumina Board Of Directors Elects Dr. Scott Gottlieb Chair, Keith Meister To Join Board Of Directors - MarketScreener
Illumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors - PR Newswire
Activist investor Keith Meister to join Illumina's board, WSJ reports - MSN
Illumina shares rise on WSJ report activist investor Meister will join board By Investing.com - Investing.com UK
Activist investor Meister to join Illumina's board, WSJ reports - MarketScreener
Activist Investor Keith Meister Will Join The Board Of Directors Of Illumina- WSJ - MarketScreener
Single Cell Genome Sequencing Market Detailed In New Research - openPR
High End Cellomics Market Set to Witness Significant Growth - openPR
Scaling the genomics lab for the data deluge - Illumina
Illumina CIO Carissa Rollins to retire in April By Investing.com - Investing.com Australia
Illumina CIO Carissa Rollins to retire in April - Investing.com
Interrogating challenging genomic regions provides new answers for patients - Illumina
3.49%
大文字化:
|
ボリューム (24 時間):